Literature DB >> 22144569

Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations.

Katharina Eikermann-Haerter1, Jeong Hyun Lee, Izumi Yuzawa, Christina H Liu, Zhipeng Zhou, Hwa Kyoung Shin, Yi Zheng, Tao Qin, Tobias Kurth, Christian Waeber, Michel D Ferrari, Arn M J M van den Maagdenberg, Michael A Moskowitz, Cenk Ayata.   

Abstract

BACKGROUND: Migraine is an independent risk factor for stroke. Mechanisms underlying this association are unclear. Familial hemiplegic migraine (FHM), a migraine subtype that also carries an increased stroke risk, is a useful model for common migraine phenotypes because of shared aura and headache features, trigger factors, and underlying glutamatergic mechanisms. METHODS AND
RESULTS: Here, we show that FHM type 1 (FHM1) mutations in Ca(V)2.1 voltage-gated Ca(2+) channels render the brain more vulnerable to ischemic stroke. Compared with wild-type mice, 2 FHM1 mutant mouse strains developed earlier onset of anoxic depolarization and more frequent peri-infarct depolarizations associated with rapid expansion of infarct core on diffusion-weighted magnetic resonance imaging and larger perfusion deficits on laser speckle flowmetry. Cerebral blood flow required for tissue survival was higher in the mutants, leading to infarction with milder ischemia. As a result, mutants developed larger infarcts and worse neurological outcomes after stroke, which were selectively attenuated by a glutamate receptor antagonist.
CONCLUSIONS: We propose that enhanced susceptibility to ischemic depolarizations akin to spreading depression predisposes migraineurs to infarction during mild ischemic events, thereby increasing the stroke risk.
© 2011 American Heart Association, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22144569      PMCID: PMC3276214          DOI: 10.1161/CIRCULATIONAHA.111.045096

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  57 in total

1.  Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice.

Authors:  C Ayata; G Ayata; H Hara; R T Matthews; M F Beal; R J Ferrante; M Endres; A Kim; R H Christie; C Waeber; P L Huang; B T Hyman; M A Moskowitz
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

Review 2.  Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies.

Authors:  Mahyar Etminan; Bahi Takkouche; Francisco Caamaño Isorna; Ali Samii
Journal:  BMJ       Date:  2004-12-13

3.  Transient changes in cortical glucose and lactate levels associated with peri-infarct depolarisations, studied with rapid-sampling microdialysis.

Authors:  Sarah E Hopwood; Mark C Parkin; Elizabeth L Bezzina; Martyn G Boutelle; Anthony J Strong
Journal:  J Cereb Blood Flow Metab       Date:  2005-03       Impact factor: 6.200

4.  Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine. Dutch Migraine Genetics Research Group.

Authors:  G M Terwindt; R A Ophoff; J Haan; M N Vergouwe; R van Eijk; R R Frants; M D Ferrari
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

5.  Potassium-induced cortical spreading depressions during focal cerebral ischemia in rats: contribution to lesion growth assessed by diffusion-weighted NMR and biochemical imaging.

Authors:  E Busch; M L Gyngell; M Eis; M Hoehn-Berlage; K A Hossmann
Journal:  J Cereb Blood Flow Metab       Date:  1996-11       Impact factor: 6.200

6.  Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4.

Authors:  R A Ophoff; G M Terwindt; M N Vergouwe; R van Eijk; P J Oefner; S M Hoffman; J E Lamerdin; H W Mohrenweiser; D E Bulman; M Ferrari; J Haan; D Lindhout; G J van Ommen; M H Hofker; M D Ferrari; R R Frants
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

7.  Migraine in school children. A study of the incidence and short-term prognosis, and a clinical, psychological and electroencephalographic comparison between children with migraine and matched controls.

Authors:  B S BILLE
Journal:  Acta Paediatr Suppl       Date:  1962-05

8.  Epidemiology of headache in a general population--a prevalence study.

Authors:  B K Rasmussen; R Jensen; M Schroll; J Olesen
Journal:  J Clin Epidemiol       Date:  1991       Impact factor: 6.437

9.  Cortical negative DC deflections following middle cerebral artery occlusion and KCl-induced spreading depression: effect on blood flow, tissue oxygenation, and electroencephalogram.

Authors:  T Back; K Kohno; K A Hossmann
Journal:  J Cereb Blood Flow Metab       Date:  1994-01       Impact factor: 6.200

10.  The role of spreading depression in focal ischemia evaluated by diffusion mapping.

Authors:  K Takano; L L Latour; J E Formato; R A Carano; K G Helmer; Y Hasegawa; C H Sotak; M Fisher
Journal:  Ann Neurol       Date:  1996-03       Impact factor: 10.422

View more
  55 in total

1.  Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke.

Authors:  Hwa Kyoung Shin; Fumiaki Oka; Ji Hyun Kim; Dmitriy Atochin; Paul L Huang; Cenk Ayata
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

2.  Requisite ischemia for spreading depolarization occurrence after subarachnoid hemorrhage in rodents.

Authors:  Fumiaki Oka; Ulrike Hoffmann; Jeong Hyun Lee; Hwa Kyoung Shin; David Y Chung; Izumi Yuzawa; Shih-Pin Chen; Yahya B Atalay; Ala Nozari; Kristen Park Hopson; Tao Qin; Cenk Ayata
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

3.  Exploitation of the spreading depolarization-induced cytotoxic edema for high-resolution, 3D mapping of its heterogeneous propagation paths.

Authors:  Jens P Dreier; Clemens Reiffurth
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-21       Impact factor: 11.205

4.  Abnormal synaptic Ca(2+) homeostasis and morphology in cortical neurons of familial hemiplegic migraine type 1 mutant mice.

Authors:  Katharina Eikermann-Haerter; Michal Arbel-Ornath; Nilufer Yalcin; Esther S Yu; Kishore V Kuchibhotla; Izumi Yuzawa; Eloise Hudry; Carli R Willard; Mihail Climov; Fatmagul Keles; Arianna M Belcher; Buse Sengul; Andrea Negro; Isaac A Rosen; Andrea Arreguin; Michel D Ferrari; Arn M J M van den Maagdenberg; Brian J Bacskai; Cenk Ayata
Journal:  Ann Neurol       Date:  2015-07-06       Impact factor: 10.422

Review 5.  Pharmacological targeting of spreading depression in migraine.

Authors:  Katharina Eikermann-Haerter; Anil Can; Cenk Ayata
Journal:  Expert Rev Neurother       Date:  2012-03       Impact factor: 4.618

6.  Real-time non-invasive in vivo visible light detection of cortical spreading depolarizations in mice.

Authors:  David Y Chung; Kazutaka Sugimoto; Paul Fischer; Maximilian Böhm; Tsubasa Takizawa; Homa Sadeghian; Andreia Morais; Andrea Harriott; Fumiaki Oka; Tao Qin; Nils Henninger; Mohammad A Yaseen; Sava Sakadžić; Cenk Ayata
Journal:  J Neurosci Methods       Date:  2018-09-05       Impact factor: 2.390

Review 7.  Chaos and commotion in the wake of cortical spreading depression and spreading depolarizations.

Authors:  Daniela Pietrobon; Michael A Moskowitz
Journal:  Nat Rev Neurosci       Date:  2014-06       Impact factor: 34.870

8.  Relief Following Chronic Stress Augments Spreading Depolarization Susceptibility in Familial Hemiplegic Migraine Mice.

Authors:  Mustafa Balkaya; Jessica L Seidel; Homa Sadeghian; Tao Qin; David Y Chung; Katharina Eikermann-Haerter; Arn M J M van den Maagdenberg; Michel D Ferrari; Cenk Ayata
Journal:  Neuroscience       Date:  2019-07-09       Impact factor: 3.590

Review 9.  Spreading Depression in Primary and Secondary Headache Disorders.

Authors:  Shih-Pin Chen; Cenk Ayata
Journal:  Curr Pain Headache Rep       Date:  2016-07

10.  Hyperlipidemia disrupts cerebrovascular reflexes and worsens ischemic perfusion defect.

Authors:  Cenk Ayata; Hwa Kyoung Shin; Ergin Dileköz; Dmitriy N Atochin; Satoshi Kashiwagi; Katharina Eikermann-Haerter; Paul L Huang
Journal:  J Cereb Blood Flow Metab       Date:  2013-03-13       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.